Neimeth International Pharmaceuticals Plc (NGX:NEIMETH)

Nigeria flag Nigeria · Delayed Price · Currency is NGN
8.55
-0.45 (-5.00%)
At close: Jun 11, 2026
Market Cap36.54B +140.8%
Revenue (ttm)7.91B +56.9%
Net Income984.32M
EPS0.23
Shares Out 4.27B
PE Ratio37.12
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume6,020,050
Open9.65
Previous Close9.00
Day's Range9.65 - 9.90
52-Week Range3.28 - 16.15
Beta0.65
AnalystsHold
Price Target9.49 (+10.99%)
Earnings DateJul 29, 2026

About NGX:NEIMETH

Neimeth International Pharmaceuticals Plc manufactures and markets pharmaceutical and animal health products in Nigeria and Ghana. It provides health care, ethical, and veterinary related products; and poultry and animal range of anthelmintic products, as well as production enhancing medicaments. The company was formerly known as Pfizer Inc. and changed its name to Neimeth International Pharmaceuticals Plc. In 1997. Neimeth International Pharmaceuticals Plc was incorporated in 1957 and is based in Lagos, Nigeria. [Read more]

Industry Pharmaceutical Preparations
Founded 1957
Employees 212
Stock Exchange Nigerian Stock Exchange
Ticker Symbol NEIMETH
Full Company Profile

Financial Performance

Financial Statements